<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医麦客 | wechat-feeds</title><link>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</link><description>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 18 Feb 2021 08:00:30 +0800</pubDate><image><url>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</url><title>医麦客 | wechat-feeds</title><link>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>国内首例，国健呈诺异体“现货型”CAR-NK细胞注射液治疗实体瘤临床申请获国家药监局受理丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/w5uCDlpQ4wdzCwdqfRgNNg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItPVC3Hias6FVSfu6ehjAsyrNkr2iajexKWREqwiaQX3cLmUxcnq5O1AQUmWywGIB2DUfTxKXCRVaUtA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>针对晚期上皮性卵巢癌，靶向间皮素]]></content:encoded><pubDate>Wed, 17 Feb 2021 23:58:01 +0800</pubDate></item><item><title>【2020ASH封面报道】华夏英泰创新型STAR-T获得美国血液学会官方报刊《Hematology News》首页头条关注</title><link>https://mp.weixin.qq.com/s/38C3JYEk_qnlwVnEpWyk-g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItgIlobAqsJm1bvcZO3JJexz1icvXBpibYeF1fmO4fic9vd2oEuKuKyR0Uq4sjicnCCxejYPiaycpvqYRw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Wed, 17 Feb 2021 23:58:01 +0800</pubDate></item><item><title>开发iPSC来源的CAR-NK，高达7.6亿美元的最新合作达成丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/pdLyH0DNYcdqwTWebXqEbg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIslTtqJFVN3KszBpAtS0nDKQD1HKueibYO9uUGw6d4MDOaRJYLXjUgTrCPUwc9rN1MsC8hJpCgSkvg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>iPSC来源被认为是真正意义上的“现货”方法]]></content:encoded><pubDate>Wed, 17 Feb 2021 02:02:07 +0800</pubDate></item><item><title>突发：bluebird bio宣布暂时停止LentiGlobin基因治疗镰状细胞病的1/2期和3期研究丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/64KPxrFap5eOl7a5N3Bh7g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIslTtqJFVN3KszBpAtS0nDKsPqmvTHojfn6DnMIUkpj4JAq827vAl9icic8aC1s7BxfuIsIicuo7ibyug/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>基因治疗，安全第一]]></content:encoded><pubDate>Wed, 17 Feb 2021 02:02:07 +0800</pubDate></item><item><title>药融资丨2020年中国细胞与基因治疗融资交易超155亿人民币，CAR-T依旧火热</title><link>https://mp.weixin.qq.com/s/oEJhb4lVxQ0WZPBzK4c4rw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIvnxiaeumQD30yQbxwicLVicCY163odqXYR4uCriaTemvmdk8yuA8MkNB5vH57h3WWDgBGuJtHpuI8XYg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>火热的细胞与基因治疗]]></content:encoded><pubDate>Mon, 15 Feb 2021 23:04:34 +0800</pubDate></item><item><title>药融资丨近期融资交易盘点，多家基因治疗公司完成超亿元融资</title><link>https://mp.weixin.qq.com/s/8WNU9x2jwPubbyZtBiBgkA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItp4Ljibkb28xoy4PNPMY9DjliawZe7Ymw6vRubOf1lP8qZ8s1n7ARSVWuHBA4tRVwcDbV1VYHvS87g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>医药领域重大融资事件]]></content:encoded><pubDate>Sun, 14 Feb 2021 22:39:56 +0800</pubDate></item><item><title>全文丨《基因治疗产品非临床研究与评价技术指导原则（征求意见稿）》</title><link>https://mp.weixin.qq.com/s/9C1MgwjX7W8zEHaDyybeig</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItp4Ljibkb28xoy4PNPMY9DjSANicucnictbwOGLVuPiadh59y3pL5jhLummZww4RHI3z8sJCVibTkJ1HA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Sun, 14 Feb 2021 22:39:56 +0800</pubDate></item><item><title>全文丨《溶瘤病毒类药物临床试验设计指导原则（试行）》</title><link>https://mp.weixin.qq.com/s/D11djUSdGcpXNRqx7GxmnQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItp4Ljibkb28xoy4PNPMY9DjQ73ZnmAXRlb9naNeROibakgMVT77mQs50o7f28wn964dsTIPefibxhdA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>]]></content:encoded><pubDate>Sun, 14 Feb 2021 22:39:56 +0800</pubDate></item><item><title>基于iPSC来源视网膜类器官模型，AAV基因疗法彰显潜力丨医麦黑科技</title><link>https://mp.weixin.qq.com/s/-bvv9v8DYgY1PJp6J6TDtQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuPppwdSyuUBeQ51PNZjBjNatnNnDw9ibhxgFbricrkPvO0JAsF1ib46eica6r3eRVde9fRxgnzHibarAw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>眼科罕见病新希望！]]></content:encoded><pubDate>Sun, 14 Feb 2021 00:13:03 +0800</pubDate></item><item><title>管中窥豹丨从国际巨头的2020布局出发，看未来制药风口</title><link>https://mp.weixin.qq.com/s/44rHN-PdxHX1A6pFtnehhQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItgIlobAqsJm1bvcZO3JJexFMNZdBzvia7VAl3bTpLU4boAXeYc1Dhm04Y1QgXvA8kxLrlMquE1g0g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>未来十年是生物制药的黄金十年！]]></content:encoded><pubDate>Fri, 12 Feb 2021 20:43:19 +0800</pubDate></item><item><title>J.P. Morgan 2021三天全收集，未来发展与投资风向</title><link>https://mp.weixin.qq.com/s/rOcMHBY4dSbc_gg-_HiahA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItgIlobAqsJm1bvcZO3JJexFRZpnnwt32puDDWwPExYgz00wYWDCmYTK9Vvdicv6YgsI9YswKGxCJw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>福利来了]]></content:encoded><pubDate>Fri, 12 Feb 2021 20:43:19 +0800</pubDate></item><item><title>靶向实体瘤，TCR疗法可在癌症治疗中发挥重要作用丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/UcoO2XRbA8-IsARC4FqD5A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItgIlobAqsJm1bvcZO3JJexwjKebY7seIiajFb2NAkJOgnyIpdRicewmFgp27UialCN4cpCeYZovS21A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>自体和同种异体细胞产品并存，在疾病和患者亚群之间差异使用]]></content:encoded><pubDate>Fri, 12 Feb 2021 00:17:45 +0800</pubDate></item><item><title>康威生物获得UbiVac免疫疗法癌症疫苗DPV-001大中华地区独家授权丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/pctD8g9cfF-q3FxfVrr_Hg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItr4MA9FQQvftJKLeY1pPZichkGsCibfvJc38uTceKxuZrOrnveQLrUdzJxyA9CAGgERickpTM7AuNfg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>能够显著增强晚期癌症患者的抗肿瘤免疫力]]></content:encoded><pubDate>Fri, 12 Feb 2021 00:17:45 +0800</pubDate></item><item><title>全球新冠感染率呈下降趋势！一窥接种疫苗后的“真实世界”丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/v3LZ3xl4eK03jwjxmu-nCg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIvCoeVaDbJILnDmWhbq5pibFCfDAyHk6Z7NnHTAGMTUom6xyDmwpXYYB5NtWJ2j42npQ4Oibiczolahg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>全球多少人已接种疫苗？疫苗起效了吗？]]></content:encoded><pubDate>Wed, 10 Feb 2021 22:28:33 +0800</pubDate></item><item><title>Nature子刊：重磅数据！AAV基因治疗的临床试验分析与趋势丨医麦新观察</title><link>https://mp.weixin.qq.com/s/fd0AoQhleEQdJMN6foYTJg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIvCoeVaDbJILnDmWhbq5pibF0o1uQmBHBx6wZa1lGT0Vh4AjKAudxlwicQW8ibtCLBUB2Egu1PLymWibw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>20多年，3000多名接受AAV基因治疗的患者]]></content:encoded><pubDate>Wed, 10 Feb 2021 22:28:33 +0800</pubDate></item><item><title>CAR-T全球市场持续上新，国内首款产品上市之前的商业布局成为焦点丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/rB7NcRR8OUhujYtJfyRYvA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItPVC3Hias6FVSfu6ehjAsyriaklQ2JakgxHAVaiavoOLF6WuCzWSePqoJcictauicTmSCHYr667Su3LOg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>关于定价、支付以及终端销售模式搭建的讨论]]></content:encoded><pubDate>Wed, 10 Feb 2021 08:30:16 +0800</pubDate></item><item><title>药融资 | 卡替医疗完成新一轮亿元级融资，持续领跑TIL疗法赛道</title><link>https://mp.weixin.qq.com/s/oo92cgLLPnnMTFzpVomavg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItPVC3Hias6FVSfu6ehjAsyrWOKZWckL2jiad1xDib6ibpWvYKUlCJmKRNCeoT0dr0Co3EtZOHSNsrYUQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>本次融资将用于支持卡替医疗公司的“超强型TIL”细胞治疗产品完成IND申报。]]></content:encoded><pubDate>Wed, 10 Feb 2021 08:30:16 +0800</pubDate></item><item><title>国内首例，国健呈诺异体“现货型”CAR-NK细胞注射液治疗实体瘤临床申请获国家药监局受理丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/Q56E3YB8V12ejnJ5_nGI4g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItPVC3Hias6FVSfu6ehjAsyrNkr2iajexKWREqwiaQX3cLmUxcnq5O1AQUmWywGIB2DUfTxKXCRVaUtA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>针对晚期上皮性卵巢癌，靶向间皮素]]></content:encoded><pubDate>Wed, 10 Feb 2021 08:30:16 +0800</pubDate></item><item><title>加速生物药的研发和产业化进程，澳斯康生物制药与复宏汉霖达成战略合作意向丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/qtI6J53Tg-TP7kwFYxpeyw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsG2ibH8icMEmlSWoJEMkiaRnesp3wZ83LhSPvxetic4srQRmu5LtRJo3UJMaicIHPTBIWYWqHP4dDxiaRQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>一起为全球患者提供质高价优的生物药物]]></content:encoded><pubDate>Tue, 09 Feb 2021 11:32:43 +0800</pubDate></item><item><title>重磅！国健呈诺异体外周血来源的现货型CAR-NK细胞产品临床申请获国家药监局受理丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/xM2Pmr5eZCNM6wacgwRCfQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItr4MA9FQQvftJKLeY1pPZiciaZVibLdvLbXEuEdb1sS9LVpQaicrIYsibttPWian7PC0shy9icxicKybmhuA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>CDE受理的首个用于实体瘤治疗的CAR-NK细胞产品]]></content:encoded><pubDate>Tue, 09 Feb 2021 11:32:43 +0800</pubDate></item></channel></rss>